Abstract

Abstract Chitosan (Ch) microparticles have been investigated for drug delivery through different administration routes, primarily oral. For this, synthetic crosslinking agents, such as sodium tripolyphosphate (TPP), are used to prepare these microparticles. In this sense, the objective of this study was to evaluate the potential of xanthan gum (XG) as a crosslinking agent aiming at the standardization of a natural polymer of low toxicity and low cost as an alternative to synthetic ones. The Ch-XG microparticles were prepared by the complex coacervation method and demonstrated high mucoadhesive capacity in vitro. Using green coffee extract, a phenolic-rich extract as a drug model, the microparticles crosslinked with XG showed satisfactory mean diameter (approximately 498 μm) and high entrapment efficiency (62.70 ± 5.20%.). Scanning electron microscopy, Fourier transform infrared spectroscopy, and thermogravimetric analysis proved the extract encapsulation in the polymeric matrix. Compared to conventional microparticles (Ch-TPP), Ch-XG microparticles provided a slower release of the 5-caffeoylquinic acid (5-CQA), in particular, in the simulated gastric fluid. Based on these findings, XG can be considered as a promising crosslinker for the preparation of chitosan microparticles, especially for oral drug delivery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.